Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemozoin is a dark brown biocrystal synthesized by Plasmodium falciparum and other blood-feeding parasites within their acidic digestive food vacuole. During the intraerythrocytic stage of malaria, the parasite ingests and degrades host hemoglobin to obtain amino acids, a process that releases large amounts of free, redox-active, and highly toxic heme (ferriprotoporphyrin IX). To prevent heme-induced oxidative stress, lipid peroxidation, and cellular lysis, the parasite detoxifies free heme by crystallizing it into insoluble, chemically inert hemozoin. This non-enzymatic biomineralization process is essential for parasite survival and represents a highly validated therapeutic target. Classic antimalarial drugs, such as chloroquine, quinine, and amodiaquine, act by binding to free heme or the growing crystal surface of hemozoin, thereby preventing further crystallization. This leads to a lethal accumulation of toxic free heme and heme-drug complexes within the food vacuole, ultimately killing the parasite. Because hemozoin formation is a physicochemical process unique to the parasite, targeting it offers high selectivity, though resistance has emerged primarily through mutations in vacuolar transporters like PfCRT that efflux the drugs rather than alterations in the crystallization pathway itself.
Inhibition of heme crystallization into hemozoin, leading to the accumulation of toxic free heme (ferriprotoporphyrin IX) which causes oxidative stress, membrane damage, and lysis of the malaria parasite.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemozoin (Hz).